Already a Bloomberg.com user?
Sign in with the same account.
Don't have an account?
Help! I can't access my account.
Aug. 26 (Bloomberg) -- Bloomberg’s Drew Armstrong discusses the latest major pharmaceutical deal with Amgen set to purchase Onyx. He speaks with Stephanie Ruhle and Tom Keene on Bloomberg Television’s “Market Makers.” (Source: Bloomberg)
On Air Now
Max 250 characters
©2013 Bloomberg L.P. All Rights Reserved. Made in NYC